Cannabis smoke damages lungs even without tobacco use

This exploratory study examined the respiratory health of chronic cannabis smokers using comprehensive clinical assessments including lung function tests, imaging, and symptom evaluations. The research included 58 participants who had smoked cannabis for at least five years or 100+ occasions in the past year, comparing exclusive cannabis smokers, dual users (cannabis plus tobacco), and polysubstance users. The findings reveal a concerning pattern: 29% reported chronic respiratory symptoms like cough and wheezing, 66% showed abnormalities in lung-function tests, and 57% displayed an obstructive pattern indicating airway obstruction similar to chronic bronchitis.

Despite participants being relatively young, the prevalence of respiratory issues was notably high. 47% had abnormal findings on CT chest scans, and 43% reported regular or poor general health. The study documented that cannabis smoke produces polycyclic aromatic hydrocarbons, carbon monoxide, and particulate matter—toxic compounds similar to tobacco smoke that can damage airways and lung tissue. Interestingly, no statistically significant differences were found between exclusive cannabis users and those combining cannabis with other substances, suggesting that cannabis smoking itself poses substantial respiratory risks independent of tobacco co-use.

These findings have important implications for cannabis policy and public health messaging. While the study was exploratory and relatively small, it demonstrates that chronic cannabis smoking carries measurable respiratory health consequences that warrant further investigation and user awareness. The high frequency of functional abnormalities even in young people suggests that respiratory risks may develop earlier and more substantially than previously understood, challenging assumptions about cannabis being a "safer" smoking alternative to tobacco.